Mr. Jin Xuekun is Chief Executive Officer and Executive Director of Bloomage BioTechnology Corporationrationration Limited since December 20, 2013. He was redesignated from Independent NonExecutive Director to Executive Director since October 29, 2013. He was graduated from Fordham University with a Masters degree of Business Administration in 2002. He worked at China Rehabilitation Research Center from 1987 to 1993 and was responsible for medical imaging. He worked at Chindex International Trade Company Limited from 2001 to 2006 as vice president and was responsible for the marketing of medical imaging equipment in the PRC and since 2006, Mr. Jin was the general manager of Esaote Medical Equipment Co. Ltd. Mr. Jin has over 20 years experience in the sale and marketing of medical instruments.
Age: 49  CEO Since 2013      
86 10 8567 0099  http://www.bloomagebio-tech.com

Management Efficiency

The company has return on total asset (ROA) of 7.25 % which means that it generated profit of $7.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.14 % meaning that it generated $13.14 on every $100 dollars invested by stockholders.
The company has accumulated 99.22M in total debt with debt to equity ratio (D/E) of 39.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BLOOMAGE BIOTEC has Current Ratio of 7.27 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Bloomage BioTechnology Corporationration Limited, an investment holding company, develops, manufactures, and sells biochemical solutions in the People?s Republic of China, Asia, the Americas, and internationally. BLOOMAGE BIOTEC (0963) is traded on Hong Kong Stock Exchange in Hong Kong and employs 758 people.


Waiyan Yau, Financial Controller
Wen Hai, Non-Executive Independent Director
Lili Zhan, Independent Non-Executive Director
Zhaofeng Xue, Independent Non-Executive Director
Junhong Li, Independent Non-Executive Director
Anmin Gong, CFO
Guixin Xu, Vice General Manager - Bloomage Biopharm
Chunxi Wang, Vice General Manager - Bloomage Biopharm
Ning Hu, vice general manager of Beijing Bloomage Hyinc Technology Company Limited
Aihua Wang, Executive Director
Xueping Guo, Vice General Manager and Director - Bloomage Biopharm
Yihong Luan, vice general manager of Bloomage Biopharm
Xuekun Jin, CEO, Executive Director and Member of Remuneration Committee
Ping Loong, Company Secretary
Yan Zhao, Chairman
Jiajun Guo, Non-Executive Director
Aihua Liu, Executive Director and Member of Nomination Committee

Stock Performance Indicators

Current Sentiment - 0963

BLOOMAGE BIOTEC Investor Sentiment

Most of Macroaxis users are presently bullish on BLOOMAGE BIOTEC. What is your opinion about investing in BLOOMAGE BIOTEC? Are you bullish or bearish?
50% Bullish
50% Bearish

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
See also Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com